Disappointingly, the issue of the future regulation of medical devices was barely touched upon when John Dalli, commissioner-designate for health and consumer policy at the European Commission’s DG SANCO, was “grilled” live by the European Parliament on 14 January, in readiness for its vote on the 26 European commissioners-designate later this month1...
Scrip Regulatory Affairs
18 January 2010
Amanda Maxwell
Not a subscriber ? Request a FREE Trial
Subscribe to Regulatory Affairs Pharma
RELATED CONTENT
NEWS
Scrip Regulatory Affairs News
- French bill tightens up on safety and conflicts of interest, but not drug approval criteria
- PDUFA V: predictability a key theme but US FDA urged to focus on safety too
- French govt promises "culture shock" in drug regulation, while price cuts and levies loom
- European Commission's recast meeting live on web tomorrow
Other Informa News
ANALYSIS
Regulatory Affairs Pharma Analysis
Other Informa Analysis
EDITORIALS
Regulatory Affairs Pharma Editorials
Other Informa Editorials
FEATURES
Regulatory Affairs Pharma Features
Other Informa Features
COMMENT
Regulatory Affairs Pharma Comment
Other Informa Comments
